Bodybuilding 5-Amino-1MQ CAS 42464-96-0 Weight Management Fat Burner 5 Amino 1mq 5mg 10mg
TDS 57 Inquiries
42464-96-0
Reagent Grade
99.9%
香港
yixin
10vials/box 40mg*10vials
Yes
2026-09-03
polypeptide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceNNMTi (CAS 42464-96-0) is a nicotinamide N-methyltransferase (NNMT) inhibitor that promotes myoblast differentiation. NNMT is a fundamental cytosolic biotransforming enzyme that catalyzes the N-methylation of endogenous and exogenous xenobiotics. NNMTi treatment combined with lean diet substitution accelerated improved body weight fat loss, increased whole-body lean mass to body weight ratio, reduced liver epididymal white adipose tissue weights, decreased liver adiposity, improved hepatic steatosis, relative to a lean diet substitution alone.
Brown solid.Certificates-
TDS
Basic Info-
Product Name:
5-Amino-1-methylquinolinium chloride
Other Name:5-amino-1-methylquinolin-1-ium iodide;5-Amino-1methylquinolinium iodide;5-Amino-1-methylquinolinium;NNMTi,inhibit,fusion,muSC,muscle stem cell,NNMT,Inhibitor,regenerative;NNMTi 5-amino-1MQ;1-methylquinolin-1-ium-5-amine iodide;5-Amino-1-methyl-1-quinolinium Iodide;5-amino-1MQ/5-amino-1mq
CAS No.:42464-96-0
Molecular Formula:C10H11N2.I
InChIKeys:JPEZFBFIRRAFNR-UHFFFAOYSA-N
Molecular Weight:286.11
Exact Mass:285.997
EC Number:464-196-0
Color/Form:Brown to reddish brown
Categories:
Characteristics-
PSA:
29.9
XLogP3:-1.1683
Melting Point:213-214 °C
Critical Temperature & Pressure:Store at -20°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
polypeptide
-
Location:
No. 4, 4th Floor, Building D1, Bili La Park, Lu Shang Road, Dongcheng Street, Economic and Technological Development Zone, Liaocheng City, Shandong Province
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7 days
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
101-200
-
Year of Establishment:
2025
Company Certificates-
Tirzepatide
-
Tirzepatide
-
-
Inquiry History57 Inquiries
Country Product Purchase Quantity Date Posted
Romania
5-Amino-1MQ
5 MG Oct 23, 2026
United States
5-Amino-1-methylquinolinium chloride
100 G Oct 20, 2026
Australia
5-Amino-1-methylquinolinium chloride
1 KG Oct 14, 2026
Russia
5-Amino-1-methylquinolinium chloride
100 MT Sep 23, 2026
United States
5-Amino-1-methylquinolinium chloride
10 G Sep 19, 2026
Germany
5 amino 1mq
10 G Aug 24, 2026
United States
5 Amino 1 Mq
1000 PCS Aug 21, 2026
Lithuania
5-amino-1
100 MG Aug 12, 2026
Germany
5 amino 1mq
1 MT Aug 4, 2026
United States
5 amino 1 mmq
1 KG Jul 11, 2026
United States
5-Amino-1mq
3 G Jun 10, 2026
United States
5-Amino-1-methylquinolinium Chloride 5 amino 1mq
110 G Jun 6, 2026
United States
5-amino-1mq
1 KG Jun 4, 2026
United States
Epitalon, NAD+, DSIP, 5-Amino-1MQ, PEG-MGF
1 May 9, 2026
United States
99% peptide raw powder
1 G May 8, 2026
Netherlands
Powder or capsules 5-Amino-1-methylquinolinium chloride (5-Amino-1MQ) CAS 42464-96-0
10 G Apr 13, 2026
United States
5-amino
10 MT Apr 8, 2026
Canada
5 amino 1 mq chloride
200 G Mar 31, 2026
Malaysia
Bodyybuilding 5-Amino-1mq CAS 42464-96-0 Fat Burning Weight Loss 5 Amino 1mq
10 G Mar 24, 2026
New Zealand
NNMTi/5-amino-1MQ CAS number 42464-96-0
2 KG Mar 15, 2026 Post an enquiry for this product
More from this Seller
-
-
-
PNC27 Factory Direct Sales From China Research-Grade Polypeptide Freeze Dried Powder Best Peptides Stable Batch Consistency
Cosmetics Grade / 99%
$80/UNIT FOB
-
-
-
-
RT10 Various Peptide Specs, Ultra-High Purity Low Cost
Laboratory Grade / 99.98%
$65/UNIT FOB
-
Tirzepatide (LY3298176) is a dual glucose-dependent polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide. Tirzepatide, also known as LY 3298176, is a dual glucose-dependent polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies reported that tirzepatide mimics the actions of natural GIP at the GIP receptor. Tirzepatide was approved for improving blood sugar control in adults with type 2 diabetes, as an additio 

